Financial PR and IR for smallcap and AIM companies

London
Joined May 2009
Today we announced that Hargreaves has been selected by @sizewellc for the design, procurement, manufacture, installation, testing and commissioning of 3 foul water treatment facilities for the Sizewell C nuclear power project. #SizewellC #Nuclear #Energy #Infrastructure
1
1
56
Walbrook PR retweeted
⚙️@AmcomriGroup (AIM: #AMCO) will hold an online investor presentation to cover the H1 26 results and prospects at 11.00 a.m. on Wednesday 16 September 2026 Register via the link: engageinvestor.com/event/6a7…
1
109
Walbrook PR retweeted
☑️#NAS investee #SPI has reached agreement with Tulip UK Bidco Limited on the terms of a recommended cash offer for the Company ✔️ 250 pence per Spire share, a 66.2% premium to Spire's closing share price of 150.4p on the day prior to the Possible Offer Announcement
1
1
2
91
Read the announcement here: londonstockexchange.com/news…
1
63
Walbrook PR retweeted
✔️In case you missed it, Christopher Mills, CEO of NASCIT (LSE: #NAS), joined Martin Kimber and Matt Kenyon in the @CityAM studio last week. Watch here: youtu.be/UPrvW9OTtAs?si=JRM5…
Labour’s plan for 1.5 million new homes faces a massive capital shortfall. Harwood Group CEO Christopher Mills explains on City AM’s Business As Usual why scaling production requires £20bn in extra working capital that the housing sector simply cannot access 🏠📈 Watch the whole episode here: youtu.be/UPrvW9OTtAs #HouseBuilding #UKEconomy #PropertyMarket #UKHousing #UKBusiness
1
149
Walbrook PR retweeted
✔️#NAS has announced the partial sale of Coventbridge Group Limited ✔️ Partial sale will result in the repayment of the 10% loan note plus interest amounting to c. £5.9m and approximately a further £8.0m from a distribution from Harwood Private Equity IV 📈 Total return on the..
1
1
87
Walbrook PR retweeted
CelLBxHealth CEO on strategy reset and growth plans @Parsortix proactiveinvestors.com/compa… #Health #Biotech #Cancer #Oncology
2
3
622
Walbrook PR retweeted
✅Christopher Mills, CEO of @NASCInvTrust (AIM: #NAS) be presenting at Mello Events 2026 on Wednesday 3 June at 10:10 📍 The Clayton Hotel & Conference Centre, Chiswick, West London, W4 5RY 📅 Wednesday 3 June ⏲️ 10:10 melloevents.com/mello2026
1
106
Walbrook PR retweeted
☑️@time_finance (AIM: #TIME) will be presenting at Mello Events 2026 on Wednesday 3 June at 12:10 & at 13:20 Ed Rimmer CEO, and James Roberts CFO, will be presenting on the day and will be hosting a hot stand for post-presentation Q&A
1
1
109
Walbrook PR retweeted
✅@AmcomriGroup (AIM: #AMCO) will be presenting at Mello Events 2026 on Tuesday 2 June at 12:10 & at 13:20 Hugh Witcomb CEO, Mark O'Neill COO, and Siobhan Tyrrell CFO will be presenting on the day and will be hosting a hot stand for post-presentation Q&A
1
1
113
Walbrook PR retweeted
✅@Abingdon_Health will be presenting at @MelloEventsUK 2026 🗣️Executive Chair, Dr Chris Hand, & CFO, Tom Hayes, will present twice & will also host an exhibitor stand ⏲️11:35 & 16:10 📅Tuesday 2 June 📍The Clayton Hotel & Conference Centre, Chiswick, West London, W4 5RY
1
1
139
Walbrook PR retweeted
✅@onehealthgroup will be presenting at @MelloEventsUK 2026 🗣️Chairman, Derek Bickerstaff, and CEO, Adam Binns, will present twice & will also be hosting an exhibitor stand ⏲️ 9:00 & 14:45 📅Tuesday 2 June 📍The Clayton Hotel & Conference Centre, Chiswick, West London, W4 5RY
1
1
130
Walbrook PR retweeted
➡️@WalbrookPR has updated our two-page company summary. What's covered? 📈 Investment profile 🏢Company profile 📊 Debt restructure 👉Group strategy & outlook 🤝Business wins/opportunities #MDZ Download here 👇 🔗walbrookpr.com/docs/librarie…
1
94
📺 Watch our CEO, Anthony Tennyson, discuss transformational FY2025 with @proactive_x #SVNS
2
6
571
@Solvonis FY2025 results: transformation complete $SVNS has: - a Phase 3 lead asset in severe AUD (SVN-001) - a U.S.-focused AUD programme in Phase 2 planning (SVN-002) - an expanding proprietary CNS pipeline 🔗solvonis.com/news/financial-… #biotech #CNS #AUD
1
5
7
250
@Solvonis has appointed @WTR_Research to support US market understanding, refinement of Company profile, and expanded US institutional investor reach Relevant to key programmes: SVN-002, SVN-015 and SVN-114. 🔗solvonis.com/news/solvonis-a… $SVNS #biotech #addiction #psychiatry
4
8
374
🚀 𝗕𝗶𝗴 𝗻𝗲𝘄𝘀: 𝗔𝗯𝗶𝗻𝗴𝗱𝗼𝗻 𝗛𝗲𝗮𝗹𝘁𝗵 𝗶𝘀 𝗻𝗼𝘄 𝘁𝗿𝗮𝗱𝗶𝗻𝗴 𝗶𝗻 𝘁𝗵𝗲 𝗨𝗦𝗔! We're live on #𝗢𝗧𝗖𝗤𝗕 𝗩𝗲𝗻𝘁𝘂𝗿𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 under the ticker $𝗔𝗕𝗗𝗫𝗙. [#AIM: $ABDX] 🌎 tinyurl.com/OTCQB-ABDXF-Laun… @OTCMarkets @WalbrookPR @Cavendish_plc #ABDX #ABDXF
1
1
136